Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7DU5

The structure of the M.tb MazF-mt1 toxin in complex with a fragment of cognate antitoxin

Summary for 7DU5
Entry DOI10.2210/pdb7du5/pdb
DescriptorEndoribonuclease MazF9, A fragment of MazE-mt1 (2 entities in total)
Functional Keywordsmycobacterium tuberculosis, mazf, cocrystal structure, antibacterial peptide, toxin
Biological sourceMycobacterium tuberculosis H37Rv
More
Total number of polymer chains3
Total formula weight28467.19
Authors
Xie, W.,Chen, R. (deposition date: 2021-01-08, release date: 2022-01-12, Last modification date: 2023-11-29)
Primary citationChen, R.,Zhou, J.,Xie, W.
Mechanistic Insight into the Peptide Binding Modes to Two M. tb MazF Toxins.
Toxins, 13:-, 2021
Cited by
PubMed Abstract: Tuberculosis (TB) is a contagious disease caused by (). It is regarded as a major health threat all over the world, mainly because of its high mortality and drug-resistant nature. Toxin-antitoxin (TA) systems are modules ubiquitously found in prokaryotic organisms, and the well-studied MazEF systems (MazE means "what is it?" in Hebrew) are implicated in the formation of "persister cells" in the pathogen. Here, we report cocrystal structures of MazF-mt1 and -mt9, two important MazF members responsible for specific mRNA and tRNA cleavages, respectively, in complexes with truncated forms of their cognate antitoxin peptides. These peptides bind to the toxins with comparable affinities to their full-length antitoxins, which would reduce the RNA-cleavage capacities of the toxins in vitro. After structural analysis of the binding modes, we systemically tested the influence of the substitutions of individual residues in the truncated MazE-mt9 peptide on its affinity. This study provides structural insight into the binding modes and the inhibition mechanisms between the MazE/F-mt TA pairs. More importantly, it contributes to the future design of peptide-based antimicrobial agents against TB and potentially relieves the drug-resistance problems by targeting novel proteins.
PubMed: 33925254
DOI: 10.3390/toxins13050319
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.65 Å)
Structure validation

246333

数据于2025-12-17公开中

PDB statisticsPDBj update infoContact PDBjnumon